HSIC - HENRY SCHEIN INC

QQQ $ 612.27 $ 0.73 (0.12 %)

DIA $ 469.99 $ 2.87 (0.61 %)

SPY $ 672.42 $ 0.89 (0.14 %)

TLT $ 91.99 $ 0.00 (-0.01 %)

GLD $ 380.86 $ -5.88 (-1.52 %)

Previous Close

$ 63.93

Open

$ 64.04

Bid

$ 63.84 x 8

Ask

$ 63.90 x 75

Day's Range

$ 63.65 - $ 64.16

52 Week Range

$ 60.56 - $ 82.49

Volume

1,328,762

Average Volume

Market Cap

7.75B

Beta (5Y Monthly)

$ 0.62

PE Ratio (TTM)

$ 19.93

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-28-2025	10-Q
2	05-05-2025	03-29-2025	10-Q
3	02-25-2025	12-28-2024	10-K
4	11-05-2024	09-28-2024	10-Q
5	08-06-2024	06-29-2024	10-Q
6	05-07-2024	03-30-2024	10-Q
7	02-28-2024	12-30-2023	10-K
8	11-28-2023	09-30-2023	10-Q
9	08-07-2023	07-01-2023	10-Q
10	05-09-2023	04-01-2023	10-Q
11	02-21-2023	12-31-2022	10-K
12	11-01-2022	09-24-2022	10-Q
13	08-02-2022	06-25-2022	10-Q
14	05-03-2022	03-26-2022	10-Q
15	02-15-2022	12-25-2021	10-K
16	11-02-2021	09-25-2021	10-Q
17	08-03-2021	06-26-2021	10-Q
18	05-04-2021	03-27-2021	10-Q
19	02-17-2021	12-26-2020	10-K
20	11-02-2020	09-26-2020	10-Q
21	08-04-2020	06-27-2020	10-Q
22	05-05-2020	03-28-2020	10-Q
23	02-20-2020	12-28-2019	10-K
24	11-05-2019	09-28-2019	10-Q
25	08-06-2019	06-29-2019	10-Q
26	05-07-2019	03-30-2019	10-Q
27	02-20-2019	12-29-2018	10-K
28	11-06-2018	09-29-2018	10-Q
29	08-06-2018	08-06-2018	10-Q
30	05-08-2018	05-08-2018	10-Q
31	02-21-2018	02-21-2018	10-K
32	11-06-2017	11-06-2017	10-Q
33	08-08-2017	08-08-2017	10-Q
34	05-09-2017	05-09-2017	10-Q
35	02-21-2017	12-31-2016	10-K
36	11-02-2016	11-02-2016	10-Q
37	08-04-2016	08-04-2016	10-Q
38	05-03-2016	03-26-2016	10-Q
39	02-10-2016	12-26-2015	10-K
40	11-04-2015	09-26-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Biomerica Enters Marketing Partnership Wit...
10/16/2025 12:22:00

Biomerica, Inc. (NASDAQ:BMRA), a global biomedical company, announced today a marketing services arrangement with Henry Schein,...

Biomerica Partners With Henry Schein To Ma...
10/16/2025 12:21:54

- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributo...

Peering Into Henry Schein Inc's Recent Sho...
10/02/2025 17:00:46

What Analysts Are Saying About Henry Schei...
09/23/2025 20:01:02

henry-schein-sees-steady-smile-as-dental-market-growth-holds-analyst

Henry Schein Sees Steady Smile As Dental M...
09/23/2025 18:24:37

Henry Schein sees steady dental market trends, with Piper Sandler expecting stronger equipment growth in the second half of 2025.

Barrington Research Maintains Outperform o...
09/23/2025 15:10:53

Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and maintains $78 price t...

Henry Schein Authorizes $750M Share Repurc...
09/09/2025 21:13:20

Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care products and services to office-based dental ...

What Analysts Are Saying About Henry Schei...
08/26/2025 12:01:57

this-henry-schein-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday

This Henry Schein Analyst Turns Bullish; H...
08/26/2025 11:41:50

Evercore ISI Group Upgrades Henry Schein t...
08/26/2025 11:21:10

Evercore ISI Group analyst Elizabeth Anderson upgrades Henry Schein (NASDAQ:HSIC) from In-Line to Outperform and announces $...

Oral Genome Partners With Henry Schein To ...
08/12/2025 11:44:47

Oral Genome, a leading innovator in salivary testing, today announced a strategic partnership with Henry Schein, the world'...

JP Morgan Maintains Overweight on Henry Sc...
08/07/2025 21:09:16

JP Morgan analyst Rachel Vatnsdal maintains Henry Schein (NASDAQ:HSIC) with a Overweight and lowers the price target from $8...

Deep Dive Into Henry Schein Stock: Analyst...
08/06/2025 21:03:05

UBS Maintains Neutral on Henry Schein, Low...
08/06/2025 15:47:45

UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $75 to $70.

Evercore ISI Group Maintains In-Line on He...
08/06/2025 13:50:38

Evercore ISI Group analyst Ross Muken maintains Henry Schein (NASDAQ:HSIC) with a In-Line and lowers the price target from $...

henry-scheins-2025-outlook-hinges-on-strong-second-half-execution

Henry Schein's 2025 Outlook Hinges On Stro...
08/05/2025 14:16:32

Henry Schein Inc. stock down on Q2 earnings, misses EPS but beats sales. Total net sales up 3.3%, $23M in restructuring costs. ...

Henry Schein Affirms FY2025 Adj EPS Guidan...
08/05/2025 10:01:19

Henry Schein (NASDAQ:HSIC) affirms FY2025 Adj EPS guidance from $4.80-$4.94 to $4.80-$4.94 vs $4.88 analyst estimate. Affirms F...

Henry Schein Q2 Adj. EPS $1.10 Misses $1.2...
08/05/2025 10:00:46

Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.10 per share which missed the analyst consensus estimate of $1.20 ...

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

Assessing Henry Schein: Insights From 6 Fi...
07/25/2025 20:00:53

The Smart Money Is Buying These 10 Stocks
05/20/2025 20:50:22

Are Elon Musk And Twitter A Hindrance To Y...
04/20/2022 22:00:03